Condition: Loiasis · Sponsor: Programme National de Lutte contre l'Onchocercose, Republic of the Congo
The aim of the study is to evaluate the safety and efficacy of a 3- and 5-day course of levamisole (2.5 mg/kg) in management of loiasis microfilaremia.
This description comes directly from the study's public registry record.
Jéremy CAMPILLO, PharmD PhD · +33 4 67 41 61 52 · jeremy.campillo@ird.fr
Bachiratou SAHM · bachiratou.sahm@ird.fr
Always discuss trial participation with your own doctor first.
| Supervisor | Sibiti, Komono, Republic of the Congo | Recruiting |
| General Supervisor | Sibiti, Mokassi, Republic of the Congo | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06252961